Drugs / WS® 1442
last change Feb 2011 re-read 3 minutes ago

WS® 1442

Developed for
obesity disorder
Investigated by
Dr. Willmar Schwabe GmbH & Co. KG

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00982501 Jun 2008 → Sep 2010 obesity disorder Dr. Willmar Schwabe GmbH & Co. KG Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as WS 1442 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00982501 ↗